University Eye Hospital, Centre of Ophthalmology, University Hospital Tübingen, Tübingen, Germany.
Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Acta Ophthalmol. 2021 Mar;99(2):e247-e252. doi: 10.1111/aos.14563. Epub 2020 Aug 6.
Acute central retinal artery occlusion (CRAO) induces ischaemic retinal oedema. The purpose of this study was to define sensitivity and specificity of optical coherence tomography (OCT) based retinal thickness analysis in determining ischaemia onset in CRAO.
The relative retinal thickness increase (RRTI) in comparison with the fellow eye was analysed retrospectively in OCT scans of 66 patients diagnosed with CRAO between January 2010 and December 2019 within 48 hr of ischaemia onset. The natural course of RRTI and the sensitivity and specificity of OCT-based determination of ischaemia onset in identifying CRAO within 4.5 hr using the RRTI were evaluated.
Relative retinal thickness increase (RRTI) in acute CRAO follows a hyperbolic curve with a steep incline within the early phase after which it reaches a plateau. Optical coherence tomography (OCT)-based retinal thickness analysis in CRAO allows to differentiate patients with ischaemia onset within the past 4.5 hr or thereafter with a sensitivity of 100% and a specificity of 94.3%.
Relative retinal thickness increase (RRTI) allows to identify CRAO patients that are eligible for a potentially beneficial reperfusion therapy within a therapeutic window of 4.5 hr with a high accuracy. Especially in patients with unknown ischaemia onset, this diagnostic tool could be of major importance in the future clinical management.
急性中央视网膜动脉阻塞(CRAO)可引起视网膜缺血性水肿。本研究旨在确定基于光相干断层扫描(OCT)的视网膜厚度分析在确定 CRAO 缺血发作中的敏感性和特异性。
回顾性分析了 2010 年 1 月至 2019 年 12 月期间在缺血发作后 48 小时内诊断为 CRAO 的 66 例患者的 OCT 扫描中相对视网膜厚度增加(RRTI)与对侧眼的比较。评估了 RRTI 的自然病程以及使用 RRTI 在 4.5 小时内确定 CRAO 缺血发作的 OCT 基于视网膜厚度分析的敏感性和特异性。
急性 CRAO 的相对视网膜厚度增加(RRTI)呈双曲线曲线,在早期阶段急剧上升,之后达到平台期。基于 OCT 的 CRAO 视网膜厚度分析可以区分在过去 4.5 小时内或之后发生缺血发作的患者,其敏感性为 100%,特异性为 94.3%。
相对视网膜厚度增加(RRTI)可以准确地识别在 4.5 小时治疗窗口内有潜在益处的再灌注治疗的 CRAO 患者。特别是对于缺血发作时间未知的患者,这种诊断工具在未来的临床管理中可能具有重要意义。